Ambulatory management of primary pneumothorax: a randomised controlled trial

CTRG (University of Oxford)0 个研究点目标入组 236 人开始时间: 2015年8月6日最近更新: 2023年9月26日

适应症

试验速览

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32622394/ results (added 06/07/2020) 2022 Other publications in http://dx.doi.org/10.1136/thoraxjnl-2021-218479 Cost-effectiveness (added 12/09/2023) 2019 Protocol article in http://dx.doi.org/10.1136/bmjresp-2019-000403 (added 12/09/2023)

•1. Presenting with primary spontaneous pneumothorax as confirmed by a chest radiograph or a CT scan
•2. Age >= 16 years old and <= 55 years old
•3. Ability to consent to participation

•1. Known or suspected underlying lung disease (including >20 pack year smoking history)
•2. Evidence of tension pneumothorax (these patients should be treated immediately as medical emergencies).
•3. Females who are pregnant or lactating
•4. Inability to consent or comply with the trial requirements
•5. Contraindication to thoracic procedure. (Only applies to patients being enrolled into Intervention or Control arms – i.e. not observational cohort)
•6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial

发起方

CTRG (University of Oxford)